"Leukopenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
| Descriptor ID |
D007970
|
| MeSH Number(s) |
C15.378.553.546
|
| Concept/Terms |
Leukopenia- Leukopenia
- Leukopenias
- Leukocytopenia
- Leukocytopenias
|
Below are MeSH descriptors whose meaning is more general than "Leukopenia".
Below are MeSH descriptors whose meaning is more specific than "Leukopenia".
This graph shows the total number of publications written about "Leukopenia" by people in this website by year, and whether "Leukopenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukopenia" by people in Profiles.
-
Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells. J Immunol. 2010 Feb 15; 184(4):1737-47.
-
Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2655-66.
-
Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1432-8.
-
Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9.
-
A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 1996 Oct; 63(1):101-4.
-
Effect of LTB4 receptor antagonists in endotoxic shock in the rat. Circ Shock. 1991 Aug; 34(4):385-92.
-
Effect of the LTD4 receptor antagonist LY203647 on endotoxic shock sequelae in the rat. Eur J Pharmacol. 1991 Jun 25; 199(2):221-5.
-
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol. 1989 Oct; 7(10):1462-8.
-
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989 Apr; 33(1):68-70.
-
Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the rat. J Pharmacol Exp Ther. 1988 Oct; 247(1):363-71.